This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Set up a zero based budget for couples to clearly assign funds, support shared goals, and improve financial harmony.
18,446 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A major Taiwan chipmaker plans to double the size of its Arizona facility, a move Trump touts as a potential steeplec...
The crypto market braced for headlines as Circle faced talk of an open USD threat. Analysts argue the pullback in CRC...
Union electricians rely on a layered, hour-based pension system that can shortchange retirees if filings, vesting, or...
A broad coalition asks federal regulators to review Compass International Holdings’ data-sharing agreements with mult...
Analysts outline a path for Amazon to approach $300 in the next 12-15 months, anchored by cloud, ads, and Prime-drive...
U.S. markets wobbled as Opendoor dropped on margin concerns while housing demand hints kept some optimism alive. This...
Samsung and Dunamu say they were listed as members of the OUSD stablecoin consortium without official consultation. T...
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
BiggerPockets announces the appointment of a seasoned active real estate investor as CEO, promising sharper lending i...
NVIDIA stock has fallen over the past month, triggering worries about headlines and momentum. This article breaks dow...
Prediction-market traders are pricing a US edge after Balogun’s clearance to play in the World Cup round-of-16. Marke...